INNO HOLDINGS INC. (INHD): Nasdaq/NYSE listing notice — Inno Holdings receives Nasdaq notice for bid price below $1.00; 180-day cure period

INNO HOLDINGS INC.

Received Nasdaq letter on April 12, 2024, for non-compliance with $1.00 minimum bid price rule.
Stock has closing bid price below $1.00 for 30 consecutive business days.
Has until October 9, 2024 to regain compliance by closing at $1.00+ for 10 consecutive days.
If not cured, may qualify for second 180-day period if it meets other listing standards and intends reverse split.
Company says it will monitor bid price and consider options to regain compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

INNO HOLDINGS INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

April 12, 2024, Inno Holdings Inc. (the “Company”) received a letter (the “Notice”) from The Nasdaq Stock Market notifying the Company that, because the closing bid price for its common stock has been below $1.00 per share for 30 consecutive business days, it no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”), and Listing Rule 5810(c)(3)(A) provides that a failure to meet the Minimum Bid Pri

View on SEC.gov

Browse all listing & compliance notices →

INNO HOLDINGS INC. filing history →

Source: SEC EDGAR

accession 0001493152-24-014658

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.